杨一帆, 胡卓睿, 刘鹤, 李一贤, 刘璐, 熊小峰. G蛋白调节剂的研究进展J. 药学学报, 2022, 57(10): 2921-2931. DOI: 10.16438/j.0513-4870.2022-0656
引用本文: 杨一帆, 胡卓睿, 刘鹤, 李一贤, 刘璐, 熊小峰. G蛋白调节剂的研究进展J. 药学学报, 2022, 57(10): 2921-2931. DOI: 10.16438/j.0513-4870.2022-0656
YANG Yi-fan, HU Zhuo-rui, LIU He, LI Yi-xian, LIU Lu, XIONG Xiao-feng. Research progress on the G protein modulatorsJ. Acta Pharmaceutica Sinica, 2022, 57(10): 2921-2931. DOI: 10.16438/j.0513-4870.2022-0656
Citation: YANG Yi-fan, HU Zhuo-rui, LIU He, LI Yi-xian, LIU Lu, XIONG Xiao-feng. Research progress on the G protein modulatorsJ. Acta Pharmaceutica Sinica, 2022, 57(10): 2921-2931. DOI: 10.16438/j.0513-4870.2022-0656

G蛋白调节剂的研究进展

Research progress on the G protein modulators

  • 摘要: 异源三聚体G蛋白是一类能与鸟嘌呤核苷酸结合, 具有GTP水解酶活性的信号转导蛋白。G蛋白由αβγ三个亚基组成, 是GPCR信号通路中“分子开关”。异常活化的G蛋白与葡萄膜黑色素瘤、哮喘等疾病直接相关, 直接靶向G蛋白是上述疾病有前景的治疗策略。本文将简述G蛋白的分类及生理功能, 并综述G蛋白与疾病的关系以及G蛋白调节剂的研究进展。

     

    Abstract: Heterotrimeric G proteins are classes of signal-transducing proteins that bind to guanine nucleotides and possess GTP hydrolase activity. G proteins are composed of three subunits α, β, and γ, and are considered as the "molecular switch" in the GPCR signaling pathway. The abnormal activation of G protein is strongly related to diseases such as uveal melanoma, asthma, et al., making directly targeting G protein as an promising strategy for combating diseases. In this review, the classification and physiological functions of G protein are briefly described, and the research progress of G proteins in diseases, G protein modulators are reviewed.

     

/

返回文章
返回